← Back to patent-cliff list
CAS 1017234-21-7
3-[(1S)-1-[[(1S)-1-Phenylethyl]amino]ethyl]phenol
Codes: (III)145089-6-a
Application context (from source-drug indications)
Alzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(3-Hydroxyphenyl)ethanone→(S)-(-)-1-Phenylethylamine→3-[(1S)-1-[[(1S)-1-Phenylethyl]amino]ethyl]phenol→3-[(1S)-1-[Methyl[(1S)-1-phenylethyl]amino]ethyl]phenol→3-[1(S)-(Methylamino)ethyl]phenol→(-)-3-((1S)-1-(Dimethylamino)ethyl)phenol→N-Ethyl-N-methylamine→(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.